W. David Lewis
Lahey Hospital & Medical Center
43 Papers
768 Citations
W. David Lewis is an academic researcher from Lahey Hospital & Medical Center. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 26, co-authored 43 publications. Previous affiliations of W. David Lewis include Tufts University & Beth Israel Deaconess Medical Center.
Chat about Author
Papers
Guideline of transthyretin-related hereditary amyloidosis for clinicians
Yukio Ando,Teresa Coelho,John L. Berk,Márcia Waddington Cruz,Bo Göran Ericzon,Shu-ichi Ikeda,W. David Lewis,Laura Obici,Violaine Planté-Bordeneuve,Claudio Rapezzi,Gérard Said,Fabrizio Salvi +11 more
TL;DR: Providing guidance on making a definitive diagnosis, methods for disease staging and evaluation of disease progression, and discuss symptom mitigation and treatment strategies, including liver transplant and several pharmacotherapies that have shown promise in clinical trials are provided.
Aggressive Surgical Resection for Cholangiocarcinoma
TL;DR: Patient survival can be significantly improved by aggressive surgical resection, and nonoperative treatment with endobiliary expandable wire mesh stents for patients with unresectable disease remains debatable.
197
Cryptogenic cirrhosis: Clinicopathologic findings at and after liver transplantation
Gamze Ayata,Fredric D. Gordon,W. David Lewis,Elizabeth A. Pomfret,James J. Pomposelli,Roger L. Jenkins,Urmila Khettry +6 more
TL;DR: The clinicopathologic features of CC at liver transplantation (LT) are defined, the post-LT course with outcome is disease dependent with, recurrent disease seen in both nonalcoholic steatohepatitis and autoimmune liver disease and the possible pathogenetic mechanisms are defined.
186
•Journal Article
Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation
David R. Snydman,Barbara G. Werner,N. N. Dougherty,John L. Griffith,Robert H. Rubin,Jules L. Dienstag,Richard H. Rohrer,Richard B. Freeman,Roger L. Jenkins,W. David Lewis,Scott M. Hammer,Edward O'Rourke,George F. Grady,Karim A. Fawaz,Marshall M. Kaplan,Mark A. Hoffman,Andrea T. Katz,M. Doran +17 more
TL;DR: In this article, the authors studied the effect of cytomegalovirus immune globulin (CMVIG) on prevention of CMV disease and its complications in patients receiving liver transplants.
181
Liver transplantation for autoimmune hepatitis: a long-term pathologic study.
Gamze Ayata,Gamze Ayata,Fredric D. Gordon,W. David Lewis,Elizabeth A. Pomfret,James J. Pomposelli,Roger L. Jenkins,Urmila Khettry,Urmila Khettry +8 more
TL;DR: Recurrent AIH is not uncommon and was seen in 42% of patients with lymphoplasmacytic lobular, portal, and interface hepatitis, and high‐grade inflammation in native liver at LT is a strong predictor of recurrent AIH.
154